Page 40 - Read Online

Page 14 of 15 Kaya et al. Neuroimmunol Neuroinflammation 2019;6:5 I http://dx.doi.org/10.20517/2347-8659.2018.70

40. Bains M, Hall ED. Antioxidant therapies in traumatic brain and spinal cord injury. Biochim Biophys Acta 2012;1822:675-84.
41. Robert AA, Zamzami M, Sam AE, Al Jadid M, Al Mubarak S. The efficacy of antioxidants in functional recovery of spinal cord injured
rats: an experimental study. Neurol Sci 2012;33:785-91.
42. Bo W, Ren XJ. Control of demyelination for recovery of spinal cord injury. Chin J Traumatol 2008;11:306-10.
43. Borisoff JF, Chan CC, Hiebert GW, Oschipok L, Robertson GS, et al. Suppression of Rho-kinase activity promotes axonal growth on
inhibitory CNS substrates. Mol Cell Neurosci 2003;22:405-16.
44. Ferrari G, Fabris M, Gorio A. Gangliosides enhance neurite outgrowth in PC12 cells. Brain Res 1983;284:215-21.
45. Gonzenbach RR, Schwab ME. Disinhibition of neurite growth to repair the injured adult CNS: focusing on Nogo. Cell Mol Life Sci
2008;65:161-76.
46. Gorio A, Ferrari G, Fusco M, Janigro D, Zanoni R, et al. Gangliosides and their effects on rearranging peripheral and central neural
pathways. Cent Nerv Syst Trauma 1984;1:29-37.
47. Liu BP, Cafferty WB, Budel SO, Strittmatter SM. Extracellular regulators of axonal growth in the adult central nervous system. Philos
Trans R Soc Lond B Biol Sci 2006;361:1593-610.
48. Schwab ME. Nogo and axon regeneration. Curr Opin Neurobiol 2004;14:118-24.
49. Yiu G, He Z. Glial inhibition of CNS axon regeneration. Nat Rev Neurosci 2006;7:617-27.
50. Karimi-Abdolrezaee S, Billakanti R. Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects. Mol Neurobiol
2012;46:251-64.
51. Dergham P, Ellezam B, Essagian C, Avedissian H, Lubell WD, et al. Rho signaling pathway targeted to promote spinal cord repair. J
Neurosci 2002;22:6570-7.
52. Dubreuil CI, Winton MJ, McKerracher L. Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in
the central nervous system. J Cell Biol 2003;162:233-43.
53. Jalink K, van Corven EJ, Hengeveld T, Morii N, Narumiya S, et al. Inhibition of lysophosphatidate- and thrombin-induced neurite
retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein Rho. J Cell Biol 1994;126:801-10.
54. Lord-Fontaine S, Yang F, Diep Q, Dergham P, Munzer S, et al. Local inhibition of Rho signaling by cell-permeable recombinant protein
BA-210 prevents secondary damage and promotes functional recovery following acute spinal cord injury. J Neurotrauma 2008;25:1309-
22.
55. Sung JK, Miao L, Calvert JW, Huang L, Louis Harkey H, et al. A possible role of RhoA/Rho-kinase in experimental spinal cord injury
in rat. Brain Res 2003;959:29-38.
56. Gu YL, Yin LW, Zhang Z, Liu J, Liu SJ, et al. Neurotrophin expressions in neural stem cells grafted acutely to transected spinal cord of
adult rats linked to functional improvement. Cell Mol Neurobiol 2012;32:1089-97.
57. Quertainmont R, Cantinieaux D, Botman O, Sid S, Schoenen J, et al. Mesenchymal stem cell graft improves recovery after spinal cord
injury in adult rats through neurotrophic and proangiogenic actions. PLoS One 2012;7:e39500.
58. Uchida K, Nakajima H, Hirai T, Yayama T, Chen K, et al. The retrograde delivery of adenovirus vector carrying the gene for brain-
derived neurotrophic factor protects neurons and oligodendrocytes from apoptosis in the chronically compressed spinal cord of twy/twy
mice. Spine 2012;37:2125-35.
59. Donnelly EM, Lamanna J, Boulis NM. Stem cell therapy for the spinal cord. Stem Cell Res Ther 2012;3:24.
60. Wang H, Fang H, Dai J, Liu G, Xu ZJ. Induced pluripotent stem cells for spinal cord injury therapy: current status and perspective.
Neurol Sci 2013;34:11-7.
61. Beattie MS. Inflammation and apoptosis: linked therapeutic targets in spinal cord injury. Trends Mol Med 2004;10:580-3.
62. Okada S, Nakamura M, Renault-Mihara F, Mukaino M, Saiwai H, et al. The role of cytokine signaling in pathophysiology for spinal
cord injury. Inflamm Regen 2008;28:440-6.
63. Ito M, Natsume A, Takeuchi H, Shimato S, Ohno M, et al. Type I interferon inhibits astrocytic gliosis and promotes functional recovery
after spinal cordinjury by deactivation of the MEK/ERK pathway. J Neurotrauma. 2009;26:41-53.
64. Askvig JM, Watt JA. The MAPK and PI3K pathways mediate CNTF-induced neuronal survival and process outgrowth in hypothalamic
organotypic cultures. J Cell Commun Signal 2015;9:217-31.
65. Ray SK, Samantaray S, Smith JA, Matzelle DD, Das A, et al. Inhibition of cysteine proteases in acute and chronic spinal cord injury.
Neurotherapeutics 2011;8:180-6.
66. Samantaray S, Smith JA, Das A, Matzelle DD, Varma AK, et al. Low dose estrogen prevents neuronal degeneration and microglial
reactivity in an acute model of spinal cord injury: effect of dosing, route of administration, and therapy delay. Neurochem Res
2011;36:1809-16.
67. Lee JY, Choi SY, Oh TH, Yune TY. 17 beta-estradiol inhibits apoptotic cell death of oligodendrocytes by inhibiting rhoA-JNK3
activation after spinal cord injury. Endocrinology 2012;153:3815-27.
68. Bonnefont-Rousselot D, Collin F, Jore D, Gardes-Albert M. Reaction mechanism of melatonin oxidation by reactive oxygen species in
vitro. J Pineal Res 2011;50:328-35.
69. Wu UI, Mai FD, Sheu JN, Chen LY, Liu YT, et al. Melatonin inhibits microglial activation, reduces pro-inflammatory cytokine levels,
and rescues hippocampal neurons of adult rats with acute Klebsiella pneumoniae meningitis. J Pineal Res 2011;50:159-70.
70. Das A, Wallace G 4th, Reiter RJ, Varma AK, Ray SK, et al. Overexpression of melatonin membrane receptors increases calcium-binding
proteins and protects VSC4.1 motoneurons from glutamate toxicity through multiple mechanisms. J Pineal Res 2013;54:58-68.
71. Cheng A, Gerry S, Kaldis P, Solomon MJ. Biochemical characterization of Cdk2-Speedy/Ringo A2. BMC Biochem 2005;6:19.
72. Nebreda AR. CDK activation by non-cyclin proteins. Curr Opin Cell Biol 2006;18:192-8.
73. Bartek J, Lukas J. DNA damage checkpoints: from initiation to recovery or adaptation. Curr Opin Cell Biol 2007;19:238-45.
74. Attardi LD. The role of p53-mediated apoptosis as a crucial anti-tumor response to genomic instability: lessons from mouse models.
Mutat Res 2005;569:145-57.